, the computer storage titan, said it lost $70 million, or 3 cents a share, in the fourth quarter on revenue of $1.51 billion, down from $2.62 billion a year ago. The loss, which partly reflects a price war among storage hardware makers, was the company's second in a row and compared miserably with last year's net income of $562.8 million, or 25 cents a share. Still, the company managed to beat analyst estimates for a 7-cent loss on sales of $1.3 billion.
Earnings Reports & Outlooks
beat expectations by a penny, posting a second-quarter pro forma loss of $6.5 million, or 10 cents a share, compared with a loss of $4.1 million, or 6 cents a share, in the year-ago period. Analysts had been expecting a loss of 11 cents, according to Thomson Financial/First Call. Under generally accepted accounting principles, the company lost $18.8 million, or 29 cents a share, compared with $11.3 million, or 20 cents a share, in the year-ago quarter. Revenue for the quarter was $8.3 million, down from $47.9 million in the second quarter of 2001.
fourth-quarter profits fell 18% as the biotech company took a one-time charge of $20 million to settle a patent infringement suit. The company reported earnings of $59 million, or 39 cents a share, compared with net income of $72 million, or 47 cents a share, in the year-ago quarter. Excluding the charge, Biogen earned 48 cents a share in the fourth quarter, matching Wall Street's estimates. Fourth-quarter revenue totaled $280 million, compared with $245 million in the year-ago quarter. Sales of Avonex totaled $259 million in the quarter.
posted fourth-quarter operating earnings, before charges, of $1.58 billion, or 59 cents a share. The company earned 54 cents per share a year ago. Analysts were looking for fourth-quarter earnings of 59 cents a share, according to Thomson Financial/First Call. Bristol-Myers said it expects to earn $2.25 to $2.35 a share in 2002, in line with expectations. The company also said first-quarter earnings will be between 10% and 15% lower than the 63 cents it earned in the first quarter of 2001.
posted a narrower-than-expected third-quarter loss, but the company's sales continued to decline in the midst of a downturn in the semiconductor sector. The specialty chipmaker said its pro forma loss was $15.1 million, or 19 cents a share, compared with a profit of $22.4 million, or 28 cents a share, in the year-ago quarter. Wall Street had been expecting a loss of 22 cents a share, according to Thomson Financial/First Call. Sales for the quarter fell to $76.97 million from $207.99 million a year ago. The company also said it expects a fourth-quarter pro forma loss of 11 cents to 15 cents a share on revenue of $81 million to $83 million. Analysts were expecting a loss of 16 cents.
Slumping Prozac sales continue to drag down profits at
. The drugmaker posted fourth-quarter net income of $656.2 million, or 60 cents a share, down from net income of $767.3 million, or 70 cents a share, in the year-ago quarter. The earnings matched analysts' reduced estimates. Lilly's sales in the fourth quarter totaled $2.83 billion, a 5% decrease from sales of $2.98 billion in the fourth quarter last year. Lilly reiterated weak financial guidance for this year, expecting to earn between $2.70 and $2.80 a share in 2002, compared to $2.76 a share in 2001.
reported a fourth-quarter loss of $206 million, or 71 cents a share, reversing a profit of $194 million, or 66 cents a share, in the same quarter a year earlier. Sales totaled $3.36 billion, a decline of 6% from $3.56 billion the prior year. Excluding charges and nonrecurring items, the company earned 12 cents a share in the latest quarter, in line with the Thomson Financial/First Call consensus estimate. Kodak forecast first-quarter earnings of 5 cents to 15 cents a share, while Wall Street is looking for 12 cents. The company expects second-quarter earnings of 60 cents to 70 cents a share, compared with the estimate of 66 cents. For the year, the film and imaging company projected earnings of $2 to $2.60 a share. Analysts expect $2.43. Kodak also expects revenue of $13.4 billion for the year, up slightly from $13.2 billion in 2001. The company also said it expects to generate $6 billion in cash flow after dividends during the next six years.
posted net income of 21 cents a share for the fourth quarter, down from 34 cents a share in the year-ago period. Excluding items, the company earned 34 cents in the latest fourth quarter, meeting expectations. McDonald's forecast earnings of $1.47 to $1.54 a share for 2002, excluding the effects of foreign currency translation, while analysts polled by Thomson Financial/First Call are expecting a profit of $1.49. Last year, the company earned $1.25 a share, or $1.36 excluding items.
Thursday posted weaker fourth-quarter earnings and warned of slowing growth ahead. The big local phone company in the U.S. Southwest posted fourth-quarter earnings of $1.2 billion, or 37 cents a diluted share, down from the year-ago $1.3 billion, or 38 cents a share. Revenue inched up 1.2% on a comparable basis, but fell to $11.9 billion from $12.2 billion a year earlier on a reported basis.